Analysts Scream Sell! On Amedisys (AMED)

Several analysts are hitting the sell button on Amedisys Inc. AMED this morning. The stock is currently trading higher by 8.36%, at $29.01. The company reported earnings this morning, which generally missed estimates; they also lowered the FY 2010 EPS and revenue estimates. This is clearly a short covering rally. Both RBC and CRT are hitting the bids this morning, suggesting clients sell out of any AMED that they may be long, as today’s action seems grossly unwarranted. CRT has a $20 price target on the stock. Amedisys, Inc. is a provider of home health services to the chronic, co-morbid, aging American population. The company operates in two segments: home health and hospice segments.